Johnny Sumner

Mycrodose Therapeutics Inc. is a U.S.-based pharmaceutical company headquartered in San Diego, California specializing in the development of advanced drug delivery systems utilizing DEA Schedule I & III drugs and other compounds to treat cancer related conditions, mental health, and cognitive degenerative diseases. Mycrodoses California laboratory includes a transdermal department with full in-vitro and analytical capacities that allows for all intellectual property and proprietary data to remain in-house. The company believes that its IP-Protected Sustained Microdosing Technology™ is a smarter and safer approach to delivering pharmaceutical compounds to patients of all ages and allows for an expandable and scalable business model.

Bonsai’s mission is to transform the world’s most trusted content into its most trusted stores. We began in 2016 as a streetwear style and news app. Now, we’re leading the market shift toward content-driven commerce–having partnered with 30 of the world’s largest publishers and integrated more than 1,200 brands. Our technology allows users to transact natively within the content that’s inspiring them to buy. For publishers, we provide a better revenue alternative to intrusive ads and the chance to own the customer from inspiration to gratification. For merchants, we put their natively shoppable products in front of an audience at the moment purchasing intent is being formed, achieving more sales with less friction. Bonsai’s vision is to make this possible everywhere you discover products.

Mycrodose Therapeutics Inc. is a U.S.-based pharmaceutical company headquartered in San Diego, California specializing in the development of advanced drug delivery systems utilizing DEA Schedule I & III drugs and other compounds to treat cancer related conditions, mental health, and cognitive degenerative diseases. Mycrodoses California laboratory includes a transdermal department with full in-vitro and analytical capacities that allows for all intellectual property and proprietary data to remain in-house. The company believes that its IP-Protected Sustained Microdosing Technology™ is a smarter and safer approach to delivering pharmaceutical compounds to patients of all ages and allows for an expandable and scalable business model.

Bonsai’s mission is to transform the world’s most trusted content into its most trusted stores. We began in 2016 as a streetwear style and news app. Now, we’re leading the market shift toward content-driven commerce–having partnered with 30 of the world’s largest publishers and integrated more than 1,200 brands. Our technology allows users to transact natively within the content that’s inspiring them to buy. For publishers, we provide a better revenue alternative to intrusive ads and the chance to own the customer from inspiration to gratification. For merchants, we put their natively shoppable products in front of an audience at the moment purchasing intent is being formed, achieving more sales with less friction. Bonsai’s vision is to make this possible everywhere you discover products.